The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...

Incidence of venous thromboembolism remains 'substantial' despite expert guidelines and newer risk prediction scores ...

Our understanding of human placenta formation just deepened with the discovery of a gene essential to early embryonic ...

"It's a shock to look in the mirror while washing your face and see someone who doesn’t look like you," the "Alias," ...

Terrell Davis, TD, has been a mental health advocate ever since going public about his own mental health challenges. That's ...

The daily horoscope for Tuesday, December 9, 2025, is here for each zodiac sign during the Moon square Uranus, promoting bold ...

Discusses SCOPE Phase II Data: iSCIB1+ Shows Improved Progression-Free Survival in Advanced Melanoma December 11, 2025 9:00 ...

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will present a wide range of new breast cancer research at the 2025 San Antonio Breast Cancer Symposium (SABCS), highlighting ...

AI speeds discovery, but unclear patent rights for AI-designed drugs threaten exclusivity, returns, and drug-development economics.

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...

Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced ...

Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference December 8, 2025 8:00 ...